.png){kind=small}
Meningococcal B (MenB)
**************
MENB VACCINE AVAILABILITY UPDATE
Bexsero - We are unable to take any bookings for the Bexsero vaccine currently. If you would like us to contact you when appointments become available, please complete your details in the form below. Please note, Bexsero provides protection after the second dose at month 1.
https://questionnaire.semble.io/a49f038b971c66723166c7a7e23a767eb6ab8689
Trumenba – we are able to take bookings for Trumenba. Please note: Trumenba provides protection after the second dose given at month 6. Alternatively, it can be given as a 3-dose course at months 0, 1, and 5, with protection from month 1. However, this option costs more due to the additional dose.
To book, please complete this request form: https://questionnaire.semble.io/e727f1dacd9bc582fc9157b9036590a16c3190a2
**************
IF YOU ARE UNWELL
Click here for NHS advice on MenB symptoms and what to do if you are unwell:
https://www.nhs.uk/conditions/meningitis/
**************
Meningococcal disease is a name for any infection caused by bacteria called Neisseria meningitidis. It most commonly presents as Meningitis, sepsis and septicaemia (blood poisoning) which are very serious, potentially life-threatening illnesses.
The MenB vaccine protects against bacteria called “Neisseria meningitidis" type B.
There are two vaccines: Bexsero and Trumenba.
The Vaccine
Who can have this vaccine?
Bexsero is licensed for use in children from 2 months of age up to adults aged 50 years.
Trumenba is licensed for individuals aged 10 years and older.
Doses required
2-3 doses
Bexsero:
- 3 doses are required for children aged from 2 months to <2 years. The doctor will advise on the right schedule based on the child's age.
- 2 doses are required for adults and children over 2 years with at least 1 month between doses.
Trumenba:
- The standard licensed schedule is 2 doses, given 6 months apart (0 and 6 months). Antibody responses have been demonstrated after the second dose at 6 months.
- An alternative 3-dose schedule is also licensed. This consists of doses given at 0, 1, and 5 months. In clinical studies, antibody responses have been demonstrated after the second dose in this schedule, given from month 1.
Price
Price per dose
£150
Total for all doses
£300-450
How is it given?
This is an injection in the upper arm or thigh.
Other information
Protection from MenB vaccination is not expected to last indefinitely. Antibody levels are highest soon after completing the vaccination course and then decline over time, although the rate of decline varies between individuals.
Please refer to the patient leaflet for full information on this vaccine: